Board of Directors

Board of Directors

Gun-Britt Fransson, chairman of the board since 2018

Gun-Britt Fransson has more than 30 years of experience in management, business development and R&D within biotechnology, food and drug development. Until 2018 Fransson worked as VP R&D at Probi AB. Previous experience includes CEO of Alligator Bioscience AB, Research Director at Orkla Foods A / S and research-leading positions at KabiPharmacia AB. Fransson has extensive experience in board work and has held positions as Chairman and Board member, in both private and public companies, foundations and universities.


Shares in the company:
Fransson owns 53,333 shares

Fransson’s other assignments:

  • Lighthouse Life Science Consulting AB: Deputy
  • Lighthouse HB: Partner
  • MedicPen AB (publ): Board Member
  • Invent Medic Sweden AB: Board Member

Mats Persson, member of the board since 2019

Mats Persson has over 35 years of experience in marketing and licensing within the global pharmaceutical industry. Persson held the position as Head of Nordic at Tesaro, an American biotech company in oncology, recently acquired by GSK, until December 2018. He has extensive experience from senior positions at Astellas Pharma Norden/Baltic (CEO), Novo Nordisk, Pharmacia Corporation and Ferring International.


Shares in the company:
No shares

Persson’s other assignments:

  • M S Persson Consulting AB: Board Member
  • Gedea Biotech AB: Board Member
  • Nordic Rebalance a/s: Board Member

Alejandra Mørk, member of the board since 2018

Alejandra Mørk is the CEO and main shareholder of KLIFO. Previously, she worked for Nycomed Pharma for 18 years, in various management positions in drug development and lifecycle management. Alejandra is a board member of Danish Biotech and a member of the Danish Academy of Technical Sciences. She is also part of the EUCROF Paediatric Working Group.


Shares in the company:
No shares

Mørk’s other assignments:

  • iSD Immunotech ApS: Board Member
  • KLIFO Holding A/S: Board Member

Lars H. Bruzelius, member of the board since 2013

Lars H. Bruzelius is an Associate Professor in Business Administration and a management consultant with large experience from various business areas, amongst other Medtech. Bruzelius has for example held the position as Vice President and Administrative Director at Gambro AB and founded, developed, owned and acted as the CEO for management consultant companies. Bruzelius has been a member of the board in several companies and acted as investor in several start- ups, primarily within life science.


Shares in the company:
Bruzelius owns through Brushamn Invest Aktiebolag 2,798,047 shares.

Bruzelius other assignments:

  • Brushamn Holding Aktiebolag: Board Member
  • Brushamn Invest Aktiebolag: Board Member
  • Catella Fondförvaltning AB: Board Member
  • Lunds universitets stipendiestiftelse: Board Member

Anna Hultgårdh Nilsson, member of the board since 2011

Anna Hultgårdh-Nilsson, professor at Lund University, holds a Ph D in Medical Cell Biology from the Karolinska Institute. Hultgårdh-Nilsson has worked with, among other things, cell and molecular biology with a focus on vascular biology at Karolinska Institute and at Lund University. In 2011 Hultgårdh-Nilsson, together with Pontus Dunér and LU Bioscience AB, founded Follicum AB. Hultgårdh-Nilsson has published more than 60 scientific articles and has extensive experience of academic research.


Shares in the company:
Hultgårdh Nilsson and family owns 100 % of Atherioco AB which owns 657,194 shares in Follicum. Hultgårdh Nilsson and family owns a further 121,210 shares privately in Follicum.

Hultgårdh Nilssons other assignments:

  • Atherioco AB: Board Member

Carl-Johan Spak, member of the board since 2019

Carl-Johan Spak is Senior Advisor at Flerie Invest. During 2009 and 2020, he held several senior positions at Recipharm, the latest as CEO at Recipharm Venture Fund AB. He has more than 30 years’ experience in pharmaceutical industry with positions as managing director and CEO in small startup companies as well as larger pharmaceutical companies. Carl-Johan has a PhD in dentistry and pharmacology.

Carl-Johan Spak, Member of the Board, Follicum

Shares in the company:
No shares.

Spak’s other assignments:

  • Pharmacolog i Uppsala AB, Board Member
  • Symcel Sverige AB, Board Member
  • Empros Pharma AB, Board Member
  • Atrogi AB, Board Member
  • Prokarium Ltd, Board Member
  • Prokarium Holdings Ltd, Board Member
  • Kahr Medical Ltd, Board Member
  • Sweden-BIO Service AB, Board Member
  • Xspray AB, Board Member
  • Buzzard Pharmaceuticals AB, Deputy Board Member